Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase
Top Cited Papers
- 1 August 2003
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 125 (2) , 292-297
- https://doi.org/10.1016/s0016-5085(03)00939-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Treatment of HBeAg-Negative Chronic Hepatitis BSeminars in Liver Disease, 2003
- Treatment of HBe Antigen-Positive Chronic Hepatitis BSeminars in Liver Disease, 2003
- Suppressing Hepatitis B without Resistance — So Far, So GoodNew England Journal of Medicine, 2003
- Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis BNew England Journal of Medicine, 2003
- Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis BNew England Journal of Medicine, 2003
- Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeksHepatology, 2002
- Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIVGastroenterology, 2002
- Hepatitis B e antigen-negative chronic hepatitis BHepatology, 2001
- Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutantsHepatology, 2000
- Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantationJournal of Hepatology, 1997